NCT00833183View on ClinicalTrials.gov

Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne

PHASE2CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Acne

Interventions

DRUG

MAL

80 mg/g cream one administration with incubation for 90 minutes

Trial Locations (2)

H7S 2C6

Innovaderm Research Inc, Laval

H2K 4L5

Innovaderm Research Inc., Montreal

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Photocure

INDUSTRY